Search Website
The Cooperative Trials Group for Neuro-Oncology (COGNO) was established in 2007, following identification of a need to develop a central mechanism enabling a coordinated, structured approach to the management of large scale multi-centred neuro-oncology trials.
COGNO is a member of the Cooperative Clinical Trials Groups of the Clinical Oncological Society of Australia (COSA) and has a close working relationship with the COSA Neuro-Oncology Group. COGNO is funded by Cancer Australia. The group is located at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre (CTC), at the University of Sydney. The NHMRC CTC coordinates the trials activity within COGNO.
COGNO's main aim is to conduct investigator-initiated and collaborative group trials addressing important clinical questions in patients with brain tumours.

Are you interested in donating money for COGNO research activities or for other support services? If so, please complete this form and email it back to cogno@ctc.usyd.edu.au
If you would prefer to donate online, please visit http://give.sydney.edu.au/COGNO

BCBA Bike Ride for Brain Cancer Fundraiser: 9-10 March 2018
Brain Cancer Biobanking Australia (BCBA) held a 2 day fundraising Bike Ride for Brain Cancer – 250km from Sydney to the Hunter Valley -  on 9 and 10 March 2018. The date coincides with the birthday of Lucie Leonard, who died from brain cancer in 2012, and is the inspiration for the establishment of BCBA. For further information visit https://www.bikerideforbraincancer.com.au/about-the-event

Ideas or Concepts

COGNO is interested in developing new concepts into protocols and translating these into clinical research.

If you have a concept you are interested in developing, please complete this online form.

Recent News

18/07/2018: COGNO ASM Session 8: Adolescent and Young Adult, Paediatric and Rare CNS Tumours

Have you ever wondered how to treat that 35-year-old with a paediatric tumour? Or whether a 17-year-old with a GBM is the same as a 47-year-old? Although most people with a brain tumour have one of the ten most common types, even these are uncommon, and the WHO Classification of Tumours of the Central Nervous System describes over 150 tumours, meaning very rare tumours contribute a significant problem for patients and treating health practitioners. The 2018 COGNO ASM session on Adolescent and Young Adult, Paediatric and Rare CNS Tumours will address some of these challenges with talks from local and international experts who deal with them daily.

17/07/2018: COGNO: items of interest

The following may be of interest to you: Tour de Cure 2019 research funding, Stereotactic Interest Group of Australasia (SIGA) Workshop

5/07/2018: COGNO ASM Session 1: Opening Plenaries 1-3, Abstract deadline extended to 9am Wed 11 July AEST

The central theme of the meeting is 'living well with brain cancer in an era of precision treatments'. Brain tumours are particularly challenging because they can affect a patient in many different and complex ways. This mandates a multi-disciplinary approach to care and the broad expertise of our invited speakers reflects this.